CRIAM
Portable blood typing and diagnostics for emergency and remote care
- Headquarters
- Lisbon
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- criamknowledge.com
- Total Funding
- $1.3M
- Last Round
- $1.3M SeedNov 2021
About
CRIAM is a portable in vitro diagnostic company providing rapid point-of-care analysis for blood typing, sub-typing, disease detection, and nutrient measurement. The device operates without internet or power, making it suitable for use in emergency vehicles, remote locations, and resource-limited settings. CRIAM has conducted clinical trials with HCA in the US and multiple hospitals in Portugal and the UK, and is developing additional applications for infectious disease detection including COVID-19 and malaria.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account